NCT05525949已完成不适用
Treatment of Homonymous Visual Loss With Digital Therapeutics, VIVID Brain, Visual Perceptual Learning Device (HOGWAND Trial) : Multi Center, Randomized, Single-blind (Evaluator), Superiority Prove, Prospective Confirmatory Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Nunaps Inc
- 入组人数
- 93
- 试验地点
- 12
- 主要终点
- The sum of improved areas compared to baseline in the whole field
研究概览
简要总结
This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain disease. Half of participants will receive visual perceptual training using the VIVID Brain. The other half will not receive any training because there is no standard treatment for visual field defect caused by brain disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •19 years and older
- •At least 3 months after brain disease related to visual field defect
- •Verified brain disease in visual pathway related to occipital lobe, parietal lobe, temporal lobe or etc. using CT or MRI
- •Brain disease induced visual field defect
- •Able to use the VR(Virtual Reality) device
- •Able to use the app with a smart phone
- •Patient/legally authorized representative has signed the informed consent form
排除标准
- •Complete hemianopsia
- •Epilepsy, photosensitivity, Parkinson's disease
- •Bilateral visual field defect
- •Hemispatial neglect
- •Ophthalmologic disorder that may interfere the trial. (Ptosis of Eyelid, Corneal Opacity, Diabetic Retinopathy, Glaucoma, Macular Degeneration etc.)
- •Inability to discontinue psychostimulants such as methylphenidate, modafinil, and amphetamine.
- •Candidate for carotid endarterectomy or stenting
- •Received ophthalmologic surgery or laser surgery within 3 months, except for the cataract surgery
- •Pregnant or breast feeding
- •Participating in other clinical trial
- •Any other condition that, in the opinion of the investigator, precludes participation in the trial
结局指标
主要结局
The sum of improved areas compared to baseline in the whole field
时间窗: 12 weeks
The sum of areas where sensitivity increased by more than 6 dB compared to baseline in the whole field measured by Humphrey visual field test. The improved area ranges between 0 and 2,736 degree\^2, of which larger area indicates better outcome.
次要结局
- Changes in perimetric mean deviation relative to baseline in the whole field(12 weeks)
- The sum of improved areas compared to baseline in the affected hemi-field(12 weeks)
- Changes in mean total deviation relative to baseline in the affected hemi-field(12 weeks)
研究者
研究点 (12)
Loading locations...
相似试验
已完成
不适用
Visual Perceptual Learning for the Treatment of Visual Field DefectVisual Fields HemianopsiaHemianopsia, HomonymousNCT04102605Nunaps Inc80
已完成
不适用
Visual Perceptual Learning for the Treatment of Visual Field DefectVisual Field DefectStrokeNCT01959256Asan Medical Center36
招募中
不适用
Improving Visual Field Deficits With Noninvasive Brain StimulationVisual Field Defect, PeripheralVisual ImpairmentHemianopsiaQuadrantanopiaCortical BlindnessVisual Field Defect Homonymous BilateralOccipital Lobe InfarctVisual Fields HemianopsiaStrokeNCT05085210Beth Israel Deaconess Medical Center24
已完成
不适用
Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)Homonymous HemianopiaNCT01372332University Hospital Tuebingen60
已完成
不适用
Effect of Visual Retraining on Visual Loss Following Visual Cortical DamageVision Loss PartialHemianopiaHemianopia HomonymousQuadrantanopiaStroke, IschemicNCT05098236University of Rochester280